Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

People with schizophrenia can experience psychosis, a condition in which they perceive the world very differently to those around them. They may see or hear things that others cannot or hold beliefs that others find bizarre. These experiences can be distressing for those experiencing them, as well as for their families and friends. Current treatments are inadequate: they do not work for all and can lead to unpleasant side effects. But attempts to improve this are hampered by our limited understanding of schizophrenia’s biological basis.

There is no single factor that causes schizophrenia, but we know that genes are important. But neither is there a “schizophrenia gene”. Instead, many hundreds of genes act in concert to subtly increase or decrease how likely we are to become ill, given the environment in which we find ourselves.

In the last ten years, geneticists have begun to uncover the specifics of these complex relationships by identifying precisely which genes are linked with schizophrenia and other mental health conditions. For neurobiologists like me, the discovery of these genes is exciting. This information provides new clues as to which molecules and cell signalling pathways might be altered in these conditions.

Read the full article on The Conversation website, written by Dr Elizabeth Tunbridge, Associate Professor, Department of Psychiatry.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.